Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SPRUCE BIOSCIENCES, INC. Director's Dealing 2020

Oct 9, 2020

35408_dirs_2020-10-08_3b696f3a-dd1f-4166-9767-2489cb1c3d8f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: SPRUCE BIOSCIENCES, INC. (SPRB)
CIK: 0001683553
Period of Report: 2020-10-08

Reporting Person: Gharib Samir M. (Chief Financial Officer)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $1.64 2030-06-07 Common Stock (118483) Direct
Stock Option (Right to Buy) $3.07 2030-08-06 Common Stock (71548) Direct

Footnotes

F1: The shares subject to the stock option are early exercisable, subject to the Issuer's right of repurchase, and vest over a four-year period commencing May 1, 2020, with 1/4th of the shares vesting on May 1, 2021 and 1/36th of the remaining shares vesting on a monthly basis.

F2: The shares subject to the stock option are early exercisable, subject to the Issuer's right of repurchase, and vest over a four-year period commencing August 7,2020, with 1/48th of the shares vesting on a monthly basis.